ANTI-ADAM28 ANTIBODY FOR TREATING CANCER

• 1. 采用抗癌药剂和以包含非典型HLA-I及新抗原复合物为靶点的抗体的联合抗癌疗法 [P] . 中国专利： CN112351795A . 2021-02-09
• 2. CD73拮抗剂抗体和PD-1/PD-L1轴拮抗剂抗体的抗癌组合疗法 [P] . 中国专利： CN112218657A . 2021-01-12
• 3. Anti-ADAM28 antibody for treating cancer [P] . 美国专利： US10556967B2 . 2020-02-11

  机译： 抗ADAM28抗体，用于治疗癌症

• 4. Anti-ADAM28 antibody for treating cancer [P] . AU2013342779B2 . 2019-09-26

  机译： 抗ADAM28抗体，用于治疗癌症

• 5. ANTI-ADAM28 ANTIBODY FOR TREATING CANCER [P] . 欧洲知识产权局专利： EP2918678B1 . 2019-01-30

  机译： 抗癌抗体ANTI-ADAM28

• 1. Heavy Ion Irradiation Combined with HER2 Antibody Significantly Increased the Infiltration of CD8^(+) T Cells and NK Cells in HER 2-positive Breast Cancers [J] . Zhao Ting, Chen Weiqiang, Li Qiang 中国科学院近代物理研究所和兰州重离子研究装置年报：英文版 . 2019,第001期
• 2. Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody [J] . Kohei Fujita, Yuki Yamamoto, Osamu Kanai, Thoracic cancer. . 2020,第1期
• 3. A Pilot Study of Stereotactic Body Radiotherapy (SBRT) Combined with a PD-L1 Antibody Durvalumab (D) and a CTLA-4 antibody Tremelimumab (T) To Treat Metastatic Anaplastic Thyroid Cancer (ATC) [J] . Lee N., Tsai C. J., Riaz N., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期
• 4. Retreatment With Anti-PD-L1 Antibody in Advanced Non-small Cell Lung Cancer Previously Treated With Anti-PD-1 Antibodies [J] . Fujita Kohei, Uchida Naohiro, Yamamoto Yuki, Anticancer Research: International Journal of Cancer Research and Treatment . 2019,第7期
• 5. Cancer Immunotherapy Based on Engineered Novel Antibodies to Treat Cancers and Build Better Therapeutics [C] . Yanling Wu, Tianlei Ying PEGS . 2016
• 6. Harnessing Antibodies for Treating Pancreatic Cancer: AR9.6 a MUC16 Specific Monoclonal Antibody [D] . Aguilar, Eric Nunez. 2021
• 7. Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody [O] . Kohei Fujita, Yuki Yamamoto, Osamu Kanai, 2020
• 8. Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody [O] . Kohei Fujita, Yuki Yamamoto, Osamu Kanai, 2019
• 9. Neural Stem Cell Delivery of Therapeutic Antibodies to Treat Breast Cancer Brain Metastases [R] . Felding-Habermann, B. 2010

• 1. Analysis of Specific Th1/Th2 Helper Cell Responses and IgG Subtype Antibodies in Anti-CD4 Monoclonal Antibody Treated Mice with Autoimmune Cardiomyopathy [J] . Zhaohui WANG ,Yuhua LIAO ,Jing YUAN . 华中科技大学学报（医学）（英德文版） . 2008,第004期
• 2. Analysis of Specific Th1/Th2 Helper Cell Responses and IgG Subtype Antibodies in Anti-CD4 Monoclonal Antibody Treated Mice with Autoimmune Cardiomyopathy [J] . 汪朝晖 ,廖玉华 ,袁璟 . 华中科技大学学报：医学英德文版 . 2008,第004期
• 3. The Heat Shock Protein Story—From Taking mTORC1,2 and Heat Shock Protein Inhibitors as Therapeutic Measures for Treating Cancers to Development of Cancer Vaccines [J] . Peter Chin Wan Fung ,Regina Kit Chee Kong . 癌症治疗（英文） . 2017,第11期
• 4. Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis [J] . Li Yang ,Xian-Zhe Dong ,Xiao-Xuan Xing . 世界胃肠肿瘤学杂志：英文版（电子版） . 2020,第11期
• 5. 天然多克隆抗癌抗体对口腔鳞癌细胞的影响 [C] . 刘秀 ,胡颖 . 2017全国口腔生物医学学术年会 . 2017
• 6. 植物激素茉莉酸类物质和抗癌药物五氟尿嘧啶抗体的制备以及酶联免疫吸附分析方法的建立 [A] . 移明慧 . 2020